Literature DB >> 1371767

Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines.

M Lemaître1, Y Henin, F Destouesse, C Ferrieux, L Montagnier, A Blanchard.   

Abstract

In addition to previously reported tetracycline analogs, other antibiotics known for antimycoplasmal activities inhibited the cytopathic effect in CEM cl13 cells infected with human immunodeficiency virus type 1 (HIV-1) or HIV-2 but were unable to block virus replication. A contaminating mycoplasma was isolated from our CEM cl13 cells and identified as a strain of Mycoplasma fermentans. Following infection of lymphoblastoid (CEM) or promonocytic (U937 and THP1) cell lines with HIV-1, cytopathic effect was observed only in association with mycoplasmal contamination. Moreover, HIV-1 infection of U937 cells after experimental inoculation with a human isolate of M. fermentans led to pronounced cell killing. We have verified that this effect is not merely an artifact caused by arginine and/or glucose depletion in the cell culture medium. These results confirm that mollicutes, in particular M. fermentans, are able to act synergistically with HIV-1 to kill infected cells in some in vitro systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371767      PMCID: PMC257548          DOI: 10.1128/iai.60.3.742-748.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS.

Authors:  I H Chowdhury; T Munakata; Y Koyanagi; S Kobayashi; S Arai; N Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

2.  A fluoroquinolone (DR-3355) protects human lymphocyte cell lines from HIV-1-induced cytotoxicity.

Authors:  J Nozaki-Renard; T Iino; Y Sato; Y Marumoto; G Ohta; M Furusawa
Journal:  AIDS       Date:  1990-12       Impact factor: 4.177

Review 3.  Potential mechanisms for the cytopathic properties of HIV.

Authors:  R F Garry
Journal:  AIDS       Date:  1989-11       Impact factor: 4.177

4.  Ureaplasma urealyticum urease genes; use of a UGA tryptophan codon.

Authors:  A Blanchard
Journal:  Mol Microbiol       Date:  1990-04       Impact factor: 3.501

Review 5.  Replicative capacity, cytopathic effect and cell tropism of HIV.

Authors:  E M Fenyö; J Albert; B Asjö
Journal:  AIDS       Date:  1989       Impact factor: 4.177

6.  Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.

Authors:  R Pauwels; J Balzarini; M Baba; R Snoeck; D Schols; P Herdewijn; J Desmyter; E De Clercq
Journal:  J Virol Methods       Date:  1988-08       Impact factor: 2.014

Review 7.  Cytogenetic effects of mycoplasmal infection of cell cultures: a review.

Authors:  G J McGarrity; V Vanaman; J Sarama
Journal:  In Vitro       Date:  1984-01

8.  A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses.

Authors:  W C Russell; C Newman; D H Williamson
Journal:  Nature       Date:  1975-02-06       Impact factor: 49.962

9.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 10.  Interactions between mycoplasmas and the immune system.

Authors:  E Ruuth; F Praz
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

View more
  20 in total

1.  Acid phosphatase purified from Mycoplasma fermentans has protein tyrosine phosphatase-like activity.

Authors:  K Shibata; M Noda; Y Sawa; T Watanabe
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

2.  Genotypic and phenotypic analysis of Mycoplasma fermentans strains isolated from different host tissues.

Authors:  L Campo; P Larocque; T La Malfa; W D Blackburn; H L Watson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children.

Authors:  A I Hussain; W L Robson; R Kelley; T Reid; J D Gangemi
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Application of PCR for detection and identification of mycoplasma contamination in virus stocks.

Authors:  M Hu; C Buck; D Jacobs; G Paulino; H Khouri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-10       Impact factor: 2.416

5.  Molecular characterization of the P1-like adhesin gene from Mycoplasma pirum.

Authors:  T N Tham; S Ferris; E Bahraoui; S Canarelli; L Montagnier; A Blanchard
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

6.  Mycoplasma orale infection affects K+ and Cl- currents in the HSG salivary gland cell line.

Authors:  K T Izutsu; S Fatherazi; C M Belton; D Oda; F D Cartwright; G E Kenny
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

7.  Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.

Authors:  J F Mayaux; A Bousseau; R Pauwels; T Huet; Y Hénin; N Dereu; M Evers; F Soler; C Poujade; E De Clercq
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.

Authors:  Takashi Shimizu; Yutaka Kida; Koichi Kuwano
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

9.  AIDS-associated mycoplasmas possess phospholipases C in the membrane.

Authors:  K Shibata; T Sasaki; T Watanabe
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains.

Authors:  T Sasaki; Y Sasaki; M Kita; K Suzuki; H Watanabe; M Honda
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.